Predict your next investment

HEALTHCARE | Drug Development
peptimmune.com

See what CB Insights has to offer

Founded Year

2002

Stage

Dead | Dead

Total Raised

$83.55M

About Peptimmune

Peptimmune develops drugs for the treatment of various autoimmune diseases.

Peptimmune Headquarter Location

64 Sidney Street Suite 380

Cambridge, Massachusetts, 02139,

United States

617-715-8000

Latest Peptimmune News

Peptimmune Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Dec 5, 2016

Peptimmune, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 14:35 EST 5 Dec 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » Peptimmune, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Peptimmune, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Peptimmune, Inc. since January 2007. Key Findings Provides intelligence on Peptimmune, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Peptimmune, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Peptimmune, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Peptimmune, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Peptimmune Patents

Peptimmune has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/17/2005

2/2/2010

Autoimmune diseases, Immune system, Immunology, Clusters of differentiation, Transcription factors

Grant

Application Date

11/17/2005

Grant Date

2/2/2010

Title

Related Topics

Autoimmune diseases, Immune system, Immunology, Clusters of differentiation, Transcription factors

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.